NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

穿戴式注射器的全球市場:各類型,各應用領域,各最終用途市場調查,預測(∼2025年),COVID-19的累積性的影響

Wearable Injector Market Research Report by Type, by Application, by End Use, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1001016
出版日期 內容資訊 英文 193 Pages
商品交期: 最快1-2個工作天內
價格
穿戴式注射器的全球市場:各類型,各應用領域,各最終用途市場調查,預測(∼2025年),COVID-19的累積性的影響 Wearable Injector Market Research Report by Type, by Application, by End Use, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 193 Pages
簡介

全球穿戴式注射器的市場規模,預計從2020年的57億4,211萬美元,至2025年末成長為93億4,850萬美元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。目前進行的調查擴大了框架,以確保包括潛在的COVID-19問題和發展途徑。本報告提供有關COVID-19的見解,其中考慮了消費者行為和需求的變化,購買方式,供應鏈的新路由,當前市場力量的動態以及政府的重要介入等COVID-19對市場的影響相關洞察。更新的調查,考慮市場上COVID-19的影響,提供洞察,分析,估計,及預測。

本報告提供穿戴式注射器的世界市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,COVID-19的影響,各種類、應用、最終用途、地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查含括年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 應用預測
  • 種類預測
  • 最終用途預測
  • 地區預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
    • 新加入業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 各類型

  • 身體安裝型貼片注射器
  • Off Body Worn貼片注射器

第7章 各應用領域

  • 自體免疫疾病
  • 循環系統疾病
  • 糖尿病
  • 感染疾病
  • 腫瘤學

第8章 各最終用途

  • 診療所
  • 居家照護
  • 醫院
  • 線上藥局
  • 零售藥局
  • 專門診所

第9章 南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲,中東、非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第13章 企業的實用性簡介

  • Amgen Inc.
  • BASF SE
  • Becton, Dickinson and Company
  • DCA Design International Ltd
  • Debiotech S.A.
  • Debiotech S.A.
  • E3D Elcam Drug Delivery Devices
  • Enable Injections, Inc.
  • Enable Injections, Inc.
  • Gerresheimer AG
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Neuma LLC
  • SCHOTT AG
  • SONCEBOZ SA
  • Stevanato Group S.p.A.
  • Valeritas, Inc.
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG

第14章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-031AB52F47C1

The Global Wearable Injector Market size was estimated at USD 5,742.11 Million in 2020 and expected to reach USD 6,358.74 Million in 2021, at a Compound Annual Growth Rate (CAGR) 11.07% to reach USD 10,784.98 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Wearable Injector to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Wearable Injector Market was studied across Body Worn Patch Injector and Off Body Worn Patch Injector.

Based on Application, the Wearable Injector Market was studied across Autoimmune Disease, Cardiovascular Disease, Diabetes, Infectious Disease, and Oncology.

Based on End Use, the Wearable Injector Market was studied across Clinic, Home Care Setting, Hospital, Online Pharmacy, Retail Pharmacy, and Specialty Clinics.

Based on Geography, the Wearable Injector Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Wearable Injector Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Wearable Injector Market, including Amgen Inc., BASF SE, Becton, Dickinson and Company, DCA Design International Ltd, Debiotech S.A., Debiotech S.A., E3D Elcam Drug Delivery Devices, Enable Injections, Inc., Enable Injections, Inc., Gerresheimer AG, Insulet Corporation, Johnson & Johnson, Medtronic PLC, Neuma LLC, SCHOTT AG, SONCEBOZ SA, Stevanato Group S.p.A., Valeritas, Inc., West Pharmaceutical Services, Inc., and Ypsomed AG.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Wearable Injector Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wearable Injector Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wearable Injector Market?
  • 4. What is the competitive strategic window for opportunities in the Global Wearable Injector Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Wearable Injector Market?
  • 6. What is the market share of the leading vendors in the Global Wearable Injector Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Wearable Injector Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Application Outlook
  • 3.4. Type Outlook
  • 3.5. End Use Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases and high demand for advanced drug delivery device
      • 5.1.1.2. Rising demand for minimal invasive treatments
      • 5.1.1.3. Need for subcutaneous and continuous drug delivery
    • 5.1.2. Restraints
      • 5.1.2.1. Low adoption in emerging economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for biologics and mAbs
      • 5.1.3.2. Advancement in injector technology
    • 5.1.4. Challenges
      • 5.1.4.1. Preference for alternative drug delivery modes
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Wearable Injector Market, by Type

  • 6.1. Introduction
  • 6.2. Body Worn Patch Injector
  • 6.3. Off Body Worn Patch Injector

7. Wearable Injector Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Disease
  • 7.3. Cardiovascular Disease
  • 7.4. Diabetes
  • 7.5. Infectious Disease
  • 7.6. Oncology

8. Wearable Injector Market, by End Use

  • 8.1. Introduction
  • 8.2. Clinic
  • 8.3. Home Care Setting
  • 8.4. Hospital
  • 8.5. Online Pharmacy
  • 8.6. Retail Pharmacy
  • 8.7. Specialty Clinics

9. Americas Wearable Injector Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Wearable Injector Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Wearable Injector Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Amgen Inc.
  • 13.2. BASF SE
  • 13.3. Becton, Dickinson and Company
  • 13.4. DCA Design International Ltd
  • 13.5. Debiotech S.A.
  • 13.6. Debiotech S.A.
  • 13.7. E3D Elcam Drug Delivery Devices
  • 13.8. Enable Injections, Inc.
  • 13.9. Enable Injections, Inc.
  • 13.10. Gerresheimer AG
  • 13.11. Insulet Corporation
  • 13.12. Johnson & Johnson
  • 13.13. Medtronic PLC
  • 13.14. Neuma LLC
  • 13.15. SCHOTT AG
  • 13.16. SONCEBOZ SA
  • 13.17. Stevanato Group S.p.A.
  • 13.18. Valeritas, Inc.
  • 13.19. West Pharmaceutical Services, Inc.
  • 13.20. Ypsomed AG

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL WEARABLE INJECTOR MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL WEARABLE INJECTOR MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL WEARABLE INJECTOR MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2026
  • FIGURE 11. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 16. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 18. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2020 VS 2026 (%)
  • FIGURE 29. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2026
  • FIGURE 31. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CLINIC, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, 2018-2026 (USD MILLION)
  • FIGURE 40. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 42. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 44. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 46. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. CANADA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. MEXICO WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. CALIFORNIA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. FLORIDA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. ILLINOIS WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. NEW YORK WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. OHIO WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. PENNSYLVANIA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. TEXAS WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 59. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 61. CHINA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. INDIA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. JAPAN WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. THAILAND WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 70. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 71. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 72. FRANCE WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. GERMANY WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. ITALY WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. QATAR WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. SPAIN WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. GLOBAL WEARABLE INJECTOR MARKET: FPNV POSITIONING MATRIX
  • FIGURE 84. GLOBAL WEARABLE INJECTOR MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 85. GLOBAL WEARABLE INJECTOR MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 86. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL WEARABLE INJECTOR MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL WEARABLE INJECTOR MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CANADA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CANADA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. CANADA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. MEXICO WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. MEXICO WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. MEXICO WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. CALIFORNIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. CALIFORNIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CALIFORNIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. FLORIDA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. FLORIDA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. FLORIDA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ILLINOIS WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. ILLINOIS WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. ILLINOIS WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. NEW YORK WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. NEW YORK WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. NEW YORK WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. OHIO WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. OHIO WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. OHIO WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PENNSYLVANIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. PENNSYLVANIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. PENNSYLVANIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. TEXAS WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. TEXAS WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. TEXAS WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. CHINA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. CHINA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. CHINA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. JAPAN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. JAPAN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. JAPAN WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. THAILAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. THAILAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. THAILAND WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. FRANCE WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. FRANCE WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. FRANCE WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. GERMANY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. GERMANY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. GERMANY WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. ITALY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. ITALY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. ITALY WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. QATAR WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. QATAR WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. QATAR WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. SPAIN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. SPAIN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. SPAIN WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. GLOBAL WEARABLE INJECTOR MARKET: SCORES
  • TABLE 126. GLOBAL WEARABLE INJECTOR MARKET: BUSINESS STRATEGY
  • TABLE 127. GLOBAL WEARABLE INJECTOR MARKET: PRODUCT SATISFACTION
  • TABLE 128. GLOBAL WEARABLE INJECTOR MARKET: RANKING
  • TABLE 129. GLOBAL WEARABLE INJECTOR MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 130. GLOBAL WEARABLE INJECTOR MARKET: SHARE, BY COMPANY, 2020
  • TABLE 131. GLOBAL WEARABLE INJECTOR MARKET: MERGER & ACQUISITION
  • TABLE 132. GLOBAL WEARABLE INJECTOR MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 133. GLOBAL WEARABLE INJECTOR MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 134. GLOBAL WEARABLE INJECTOR MARKET: INVESTMENT & FUNDING
  • TABLE 135. GLOBAL WEARABLE INJECTOR MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 136. GLOBAL WEARABLE INJECTOR MARKET: LICENSE & PRICING
  • TABLE 137. GLOBAL WEARABLE INJECTOR MARKET: CONTACT DETAILS